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Rezumat
Tratamentul chirurgical al pseudochisturilor pancreatice
(PP) al căror management conservator eşuează a evoluat de la
abordul agresiv deschis, la cel minim invaziv. Aplicarea chirurgiei
robotice în acest context este puţin raportată. Scopul acestui studiu
este de a analiza siguranţa şi fezabilitatea abordului robotic pentru
drenajul pseudochistului pancreatic.
Acest studiu este de tip retrospectiv, unicentric şi include
o serie de pacienţi consecutivi la care s-au practicat intervenţii
chirurgicale asistate robotic pentru drenajul PP, într-un centru 
universitar terţiar.
Studiul evaluează un număr de 14 pacienţi la s-a 
practicat chisto-gastrostomie (n=10) şi chisto-jejunostomie Roux-
En-Y (n=4). Opt pacienţi au avut în antecedente pancreatită biliară
şi 3 pacienţi pancreatită alcoolică. Dimensiunea medie a
pseudochisturilor a fost de 8,9 ± 1cm şi 57,1% dintre acestea au fost
localizate la nivelul corpului pancreatic. Timpul operator total a
fost de 135 ± 34 de minute. Nu au existat conversii la operaţii
deschise. Rata generală de succes a fost de 92,8%, în timp ce rata
primară de succes a fost de 85,7%. Rata de morbiditate majoră a
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fost de 14,3%, iar mortalitatea la 30 de zile a fost 0. Durata medie de spitalizare postoperatorie a
fost de 7 ± 3 zile. Recurenţa PP a fost înregistrată într-un singur caz la care s-a practicat drenaj
endoscopic, fără recidivă ulterioară.
Abordarea robotică pentru drenarea PP simptomatic este sigură şi fezabilă şi poate fi 
considerată o procedură viabilă la pacienţi atent selectaţi.
colecţii pancreatice, pseudochisturi pancreatice, cisto-gastrostomie robotică
Abstract
The surgical treatment of pancreatic pseudocysts (PPs) in patients who fail non-
operative management has evolved from aggressive open to a minimally invasive approach. The
application of robotic surgery in this setting is scarcely reported. The aim of this study is to analyze
the safety and feasibility of the robotic approach to pancreatic pseudocyst drainage.
A single centre retrospective review of consecutive patients undergoing robotic-assisted
pancreatic pseudocyst surgeries in an academic tertiary institution was performed.
There were 14 patients studied, of whom 10 underwent cystogastrostomy and 4 Roux-En-
Y cystojejunostomy. Eight patients had gallstone pancreatitis and 3 patients alcoholic pancreatitis.
The mean size of cyst was 8.9±1cm and 57.1% located at the pancreatic body. The overall operative
time of the procedure was 135±34 minutes. There were no open conversions. The overall success rate
was 92.8%, while the primary success rate 85.7%. The major morbidity rate was 14.3% and there
was no 30-day mortality. The mean post-operative hospital stay was 7±3 days with one recurrence
of the pancreatic pseudocyst on follow-up requiring endoscopic drainage without further recurrence. 
The robotic approach for the drainage of symptomatic pancreatic pseudocyst is safe
and feasible and can be considered as a viable modality for operative intervention in well-selected
patients
pancreatic fluid collections, pancreatic pseudocysts, robotic cystogastrostomy
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Introduction
Pancreatic pseudocysts (PPs) represent a late
complication of pancreatic fluid collections
according to the revised Atlanta classification
criteria (1). They are generally homogeneous,
localized and sterile, surrounded by a well-
defined wall of fibrous or granulation tissue,
which developed as a sequela of interstitial
edematous pancreatitis (2).
In 8 to 70% of cases, PPs regress sponta-
neously within 4-6 weeks (3 - 4). Intervention is
generally considered for the treatment of PPs
that fail to resolve after a period of conservative
management (5), in case of large (> 6 cm) and
rapidly growing PPs associated with persistent
symptoms or when chronic epigastric pain or
life-threatening complications occur (6). The
goal of the operative intervention is to provide a
pathway to internal drainage thus allowing the
pseudocyst cavity to collapse; it can be 
performed through a percutaneous, endoscopic
or surgical approach (7).
Open surgery was the standard treatment
for PPs since its first description in 1931 by
Jurasz (8). In recent years, treatment has
evolved from aggressive open surgery to a
more conservative approach with minimally
invasive techniques, including laparoscopic
and endoscopic drainage, that have been
increasingly reported with lesser morbidity
and mortality in comparison with open
approach (9–10). The current data show that
endoscopic internal drainage is a safe method
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Immature fluid or necrotic pancreatic collection (< 6 weeks)
PPs that arise in the setting of chronic pancreatitis or altered pancreatic duct anatomy
Emergency operation for complicated PPs 
(infections, bleeding, perforation, pseudoaneurysm, fistula, involvement of peri cystic vessels)
Patients requiring an additional surgical procedure (ventral hernia, cholecystectomy)
Signs of portal hypertension (coagulopathy)
Suspected diagnosis of cystic neoplasia
General unsuitability for pneumoperitoneum (cardiopulmonary), insufficiency
American Society of Anesthesiologists (ASA) class >3
Patients who underwent cystoduodenostomy for cyst located around the head or uncinate process of the pancreas close 
to the duodenum
Patients who underwent pancreatic resection 
PPs: Pancreatic Pseudocysts - ASA: American Society of Anesthesiologists 
Table 1. Exclusion criteria from the study
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(11) and it is considered as a first-line treat-
ment for PPs (12). It can be achieved through
a transmural, transpapillary, or combined
approach (13).
Similarly, several laparoscopic approaches
for internal drainage have been described
including cystogastrostomy, cystoduodenostomy,
and cystojejunostomy (14). Depending on the
location of the pseudocyst, it can be accessed
through the anterior wall of the stomach/
duodenum, the lesser sac or by an endogastric
approach (15). 
The robotic approach may provide potential
advantages over traditional laparoscopic 
technique in terms of microsuturing and
microdissection capabilities, but its applica-
tion in the setting of pancreatic fluid collec-
tions treatment is scarcely reported (16-18). 
To date, few articles have investigated the
use of the robotic system for surgical drainage
of PPs. The aim of this study is to analyze the
safety and feasibility of robotic-assisted
drainage for the treatment of symptomatic
PPs.
Methods
A retrospective review was performed of all
consecutive patients who underwent robotic
PPs drainage between March 2016 and June
2019 at General Surgery Department of
Ospedali Riuniti, Palermo, Italy. 
Study exclusion criteria are illustrated in
the . All clinical cases were discussed
during the weekly multidisciplinary meeting
and all patients were managed according to 
an internal predefined protocol ( ). The
surgical approach was preferred over the
endoscopy in case of diagnosis of bile duct or
duodenal stenosis, evidence of a necrotic 
component, or in case of a large cyst that was
non-adherent to the posterior wall of the 
stomach or lack of a proper endoscopic ultra-
sound (EUS) window to perform an endoscopic
procedure. A robot-assisted cystogastrostomy
was performed in case of retro gastric cyst
while large cysts bulging through the trans-
verse mesocolon were drained by cystojejuno-
stomy.
Blood tests including tumor markers (CEA
and CA 19-9), as well as contrast-enhanced
Computed Tomography (CT) scan were 
routinely performed on patient admission for
pancreatitis and one week after the index 
scan. Imaging was evaluated by radiologists
specialized in pancreatic diseases in order to
assess the size and location of pancreatic 
collections, to differentiate between PPs and
walled-off necrosis (WONs) according to the
Revised Atlanta classification criteria and 
to detect potential vascular complications.
Abdominal ultrasonography (US) and magnetic
resonance imaging (MRI) were obtained to
quantify necrotic debris within the fluid collec-
tions. Endoscopic ultrasound (EUS) was done
in case of unclear diagnosis of acute fluid 
collections (pancreatic abscesses vs. PPs). An
EUS-guided diagnostic puncture was per-
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formed to distinguish cystic neoplasms from
PPs.
Moreover, a magnetic resonance cholangio-
pancreatography (MRCP) was performed to
obtain information on the anatomy of the 
pancreatic duct, to assess its integrity and
establish a possible communication with the
PP. A transpapillary endoscopic retrograde
cholangiopancreatography (ERCP) was per-
formed for the placement of a bridge trans-
papillary stent, when a partial pancreatic duct
disruption with leak, or a pancreatic duct 
stricture was diagnosed.
The operating time was reported as time
from skin incision until skin closure.
Intraoperative blood loss was quantified by
measuring the amount of fluid obtained from
the suction device. Conversion in the robotic
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group was intended as conversion to open 
surgery and defined as the inability to complete
the operation using the robotic approach. All 30-
days postoperative complications were graded
according to the Clavien-Dindo classification
(19). Major complications were defined as
grade ≥ 3.
For patients with multiple complications,
both complications were considered for the
analysis. Postoperative pancreatic fistula
(POPF), postoperative hemorrhage and delayed
gastric emptying were defined and graded per
the International Study Group in Pancreatic
Surgery (ISGPS) classification (20-22). 
The post-operative pain was evaluated
according to the Numeric Rating Scale (NRS-
11) (23). The NRS-11 scale was reported in a
questionnaire by each patient on postopera-
tive day 2. 
Primary therapeutic success was defined as
complete resolution of the PP by the intended
modality and confirmed on imaging method
with resolution of symptoms after 4 weeks
from the intervention. Overall success rate
was defined as clinical and radiological PP 
resolution at the last clinical follow-up assess-
ment regardless of the number of interven-
tions. Reintervention was defined as the need
for repeated intervention due to persistent
symptoms. Recurrence was defined as the
detection of a new fluid collection by imaging
studies following prior resolution or as 
reappearance of symptoms after resolution.
Readmission and perioperative mortality
were considered as those occurring during the
same hospital stay or within 30 days after dis-
charge following primary drainage procedure.
Surgical Technique
The patient is placed in a supine reverse
Trendelenburg position, with left side elevated.
After pneumoperitoneum creation, four 8-mm
robotic ports and one 11-mm assistant laparo-
scopic port are placed. 
The da Vinci Si or Xi Surgical System
(Intuitive Surgical, Sunnyvale, CA, USA) were
used to perform the surgeries. The stomach is
opened on the anterior wall using Hot
Shears™ (Monopolar Curved Scissors). The
posterior wall is opened over the pseudocyst
area after the confirmation of the location of
the pseudocyst through the intraoperative
ultrasound. The cavity is inspected, and any
necrotic pancreatic tissue is debrided if 
present. A portion of the pseudocyst wall is
sent for histological examination. The cysto-
gastrostomy is fashioned using a robotic sta-
pler or by hand-sewn anastomosis with a
barbed suture. A nasogastric tube is directed
into the PP cavity. The anterior gastrotomy in
closed in a single-layer using 4-0 V-Loc™
suture. An air test is performed to confirm
that there is no leak at the cystogastrotomy
site. 
The transverse mesocolon is lifted and the
jejunum is transected by a robotic stapler 20
cm from the ligament of Treitz. The proximal
jejunum is anastomosed to the Roux limb 60
cm distally to the transected limb via 60 mm
Robotic stapler (blue load).
The distal end is brought up to the cyst, the
location of which is assessed through an intra-
operative ultrasound probe. The jejunal wall
and the pseudocyst cavity are both opened for
3-4 cm and a biopsy is taken from the cyst
wall. A single layer cystojejunostomy anasto-
mosis is performed by two 3-0 barbed running
sutures. 
In both techniques, a perianastomotic
drain is placed. If not previously performed, a
cholecystectomy is carried out for all patients
with a previous stone-induced pancreatitis.
Postoperative Management
The nasogastric tube is removed on postopera-
tive day 1, and the patient starts a clear liquid
diet. Antibiotic-therapy is continued during
the course of the hospitalization. A follow-up
visit is scheduled at the outpatient clinic at 1,
3, and then 6 months after surgery and yearly
thereafter. A CT-scan and clinical examination
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are performed at 3 and 6 months after surgery.
At 3 months follow-up in patients who 
underwent endoscopic treatment, the trans-
mural stents are removed in case of collections
resolution.  
Statistical Analysis
Descriptive data are presented as mean ±
standard deviation (SD) and categorical data
as frequencies and percentages. Categorical
variables were tested using the chi-square,
and continuous variables were compared
using Student’s t test. All statistical analyses
were performed using SPSS version 19.0. A
95% confidence interval (CI) of the difference
in proportion was calculated. A p value of 0.05
or less was considered statistically significant. 
Results
A total of fourteen patients (n=14) were
enrolled in the study. The robotic procedures
included ten cystogastrostomy and four Roux-
en-Y cystojejunostomy ( ). 
The leading cause of pancreatic pseudo-
cysts was biliary pancreatitis (8 out of 14
patients, 57.1%).
The most common indication for robotic-
assisted cystogastrostomy was early satiety
associated with a gastric outlet obstruction
(50%), while abdominal pain was the second
indication (21.4%). The overall most common
clinical presentation was abdominal disten-
sion/ mass (35.7%).
The robotic procedure was associated with
an overall operative time of 135±34 min. The
overall success rate was 92.8% while the 
primary success rate was 85.7%.
Of the two failures of the robotic procedure,
one patient was converted to laparoscopic 
cystojejunostomy due to the firm adhesions 
in the sub-mesocolic compartment which 
hindered the mobilization of the jejunal loop
by the robotic instruments. In another patient,
due to signs of sepsis which developed from
incomplete resolution of the pancreatic fluid
collection before discharge, additional percuta-
neous drainage for residual collections with
lavage of area of colliquations was required. 
The overall morbidity rate was 28.6% with
14.3% major morbidity. Two major complica-
tions occurred. One patient developed a symp-
tomatic splenic artery pseudoaneurysm which
was diagnosed on postoperative day 6 during
an ultrasound examination due to abdominal
pain which required subsequent radiologic
embolization. A patient who underwent cysto-
Table 2. Demographic and preoperative characteristics 
of the patients involved in the study
Robotic group
(n=14)
Age (years) mean ± SD 45.9 ± 7.5
Sex, n (%)
- Male 8 (57.2%)
- Female 6 (42.8%)
BMI (Kg/m²) mean ± SD 27.8 ± 1.8
Comorbidities, n (%)
- Diabetes 3 (21.4%)
- Cardiovascular disease 2 (14.4%)
- Pulmonary disease 1 (7.1%)
- Chronic renal insufficiency 1 (7.1%)
ASA score, mean ± SD 2.7 ± 0.7 
ASA score, n (%)
- I 2 (14.3%)
- II 6 (42.8%)
- III 6 (42.8%)
Main Symptom
- Abdominal Pain 3 (21.4%)
- Nausea 2 (14.3%)
- Early satiety 7 (50%)
- Regurgitation 1 (7.1%)
- Illness / Fever 1 (7.1%)
Main Signs:
- Abdominal distension/mass 5 (35.7%)
- Vomiting 3 (21.4%)
- Jaundice 2 (14.3%)
- Weight loss 2 (14.3%)
- Melena/Hematemesis 1 (7.1%)
- Ascites 1 (7.1%)
Previous surgery, n (%) 2 (14.3%)
Etiology of Pancreatitis, n (%)
- Biliary/Gallstones 8 (57.1%)
- Alcoholic 3 (21.4%)
-  Trauma 1 (7.1%)
- Upper G.I. surgery 1 (7.1%)
- Idiopathic 1 (7.1%)
Mean size, cm, mean ± SD 8.9 ± 0.9
Site of the cyst, n (%)
- Head 1 (7.1%)
- Body 8 (57.1%)
- Tail 5 (35.7%)
Interval between onset of AP and intervention, 
days, mean ± SD 72 ± 24
Preoperative antibiotic therapy, n (%) 5 (35.7%)
SD: Standard Deviation - BMI: Body Mass Index – ASA: American Society of
Anesthesiologists – G.I.: Gastrointestinal – AP: Acute Pancreatitis 
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jejunostomy had prolonged post-operative
ileus due to an internal hernia which required
reoperation and restoration of the digestive
tract continuity.
The post-operative pain based on NRS
score was 5.9±1.9 ( ).
The mean follow-up duration was 10
months (4-28). At 3-months follow-up partial
resolution of a PP was observed in one patient.
The patient was readmitted and underwent
repeat endoscopic drainage with lavage and
stent replacement by a self-expandable 
metallic stent.
Discussion
Pancreatic Pseudocysts (PPs) are matured
peripancreatic fluid collections, resulting from
pancreatitis, trauma or pancreatic surgery (3,
24) which develop in 7-10% of patients after
acute pancreatitis, and in 10-30% after 
chronic interstitial edematous pancreatitis.
Most of the pancreatic fluid collections resolve
spontaneously (5) and their management is
based on conservative treatment for 4-6 weeks
from the onset of acute pancreatitis, during
which nutritional support, low fat diet, 
analgesics, antiemetics or antibiotics could be
administered (25). A surgical intervention is
required only in 10 to 20% of cases (26).
Over the last decades, treatment of PPs has
evolved from aggressive open surgery towards
less invasive approaches thanks to the advent
of minimally invasive techniques such as
endoscopic or laparoscopic surgery (4). Despite
the promising results offered by robotic surgery
for the treatment of pancreatic neoplasm, the
low incidence of PPs (1.6-4.5% per 100.000
adults per year) (27) and the lack of clear
advantage of robotic surgery in the setting of
emergency surgery limits the application of
robotic approach for the treatment of this 
condition. 
To the best of our knowledge, this paper
represents one of the biggest case series which
analyzes the outcome of a group of patients
who underwent robotic PPs drainage with
either cystogastrostomy or cystojejunostomy.
Our results show that these surgeries can be
performed successfully via the robotic
approach with high percentage of primary 
success and overall success. Major morbidity
rate was low at 14.3% with no mortalities. In
our experience, intra-abdominal infections
and iatrogenic injury were the most common
complications of these robotic assisted proce-
dures (28). Our results are comparable to
results of a recently published series of delayed
robotic cystogastrostomy for walled off 
pancreatic necrosis (29). The authors reported
a complication rate of 38% with a mean LOS
of 6.4 days and no mortality at 90 days. Taken
together, our series demonstrates that in well-
selected patients, robotic approach can be a
viable alternative for patients considered for
operative intervention for these indications
with encouraging outcomes.
Although some authors have reported that
endoscopic drainage of PFCs had shown 
efficacy and morbidity rate comparable to that
of surgery (30) with benefits in terms of 
hospital stay reduction, operative time, and
treatment cost (11,31), unfortunately, it is 
associated with important failure rate of 
clearance of the cavity in cases of unfavorable
anatomy. In particular, in patients with necrotic
Table 3. Postoperative outcomes of patients who underwent




Operative time, min, mean ± SD 135 ± 34
Estimated blood loss, mL, mean ± SD 75 ± 30
Primary success rate (after index procedure), n (%) 12 (85.7%)
Overall success rate, n (%) 13 (92.8%)
Conversion to laparoscopic drainage, n (%) 1 (7.1%)
Median time to oral feeding, hours, mean ± SD 46 ± 13
NRS (n), mean ± SD 5.9±1.9
Morbidity, n (%) 4 (28.8%)
- Minor 2
- Major (CDC 3) 2
Splenic artery pseudo-aneurysm (3A) 1
Internal hernia (3B) 1
Need for additional procedure, n (%) 2 (14.3%)
- Endoscopic drainage/lavage nil
- Percutaneous drainage 1
- Laparoscopic conversion drainage 1
Hospital stay (days), mean ± SD 7 ± 3
Recurrence rate, n (%) 1 (7.1%)
Mortality, n (%) nil
NRS: Numerical Rating Scale – CDC: Clavien Dindo Classification 
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tissue within PPs, the endoscopic approach is
associated with a significant intervention rate
(17-27%) due to obstructed stents (32).
Furthermore, it is associated with other com-
plications such as bleeding and perforation,
often necessitating urgent intervention (33). 
In this context and in institutions lacking
expertise in the field of advanced endoscopy or
interventional radiology, surgical therapy is
still considered the treatment of choice.
The role of laparoscopic surgery in the treat-
ment of pancreatic fluid collections is constantly
evolving (30). In a recent nationwide, 
population-based database including a total of
7060 patients, the laparoscopic approach
showed to be associated with lower transfusion
rate, post-operative morbidity, shorter mean
length of hospitalization (7 vs 11, p=0.009),
lower total charge, shorter operative time (32),
when compared with the open counterpart.
In a recent randomized trial, the initial 
success rate at 4 weeks was comparable after
the index intervention between laparoscopic
and endoscopic PPs drainage (83.3% vs 76.6%,
p=0.7). Similarly, the overall clinical success
rate and the complication rate were comparable
(93.3% vs 90%, p=1.0 and 19 vs 9, p=0.01,
respectively). Importantly, the number of
repeat procedures were higher in the endo-
scopic group (15 vs 3, p=0.0001) (35).
Similar findings were confirmed in a 
systematic review including 118 laparoscopic
and 569 endoscopic patients, where laparos-
copic series did demonstrate comparable
results with respect to endoscopic approach in
terms of initial success rate (98.3% vs 80.8%),
recurrence rate (2.5% vs 14.4%), morbidity
(4% vs 12%), and mortality (0% vs 0.4%) (36).
Melman et al. found no difference in 
complication rates and overall success rate
among surgical versus endoscopic approach
(31.5% vs 15.6% and 92.8% vs 84.6% respec-
tively), but the former was associated with a
higher primary success rate in comparison to
endoscopy (87.5% vs 51.1%) (3).
The surgical approach offers in fact the
opportunity to create a wide anastomotic 
opening of the desired size thus avoiding 
progressive dilatation and stent placement
which lead to far lower recurrence rate in 
comparison to endoscopy and more effective
control of any bleeding from the stomach wall
as well as debridement (37). A recent systematic
review including 342 patients concluded that
there is no significant difference between 
surgical and endoscopic treatment success
rates, adverse events (19.7% vs 11.5%), and
recurrence for pancreatic pseudocyst while the
length of stay was lower in the endoscopic
group (38).
The laparoscopic drainage of PFCs seems
to be technically challenging due to the 
complexity in fashioning an anastomosis in a
narrow and deep anatomical area; the lack of
dexterity of the laparoscopic instruments 
hindered its widespread adoption (39).
The robotic platform offers some advantages
over traditional laparoscopic surgery in terms
of micro suturing capabilities, the high-
definition 3-dimensional visualization and the
endo-wrist instruments which may facilitate the
creation of a complex anastomosis (40-42).
Recently, the adoption of the Endowrist 
robotic stapler enhanced the precision of 
anastomosis located in deep area as the
retroperitoneum. Finally, the software for the
intraoperative ultrasound (TilePro) can be
integrated in the robotic system and it can
used to locate the collections thus tailoring the
surgical approach (anterior or posterior
approach). In the authors’ opinion, the lack of
tactile feedback which can be considered a
potential drawback when an inflamed or fragile
tissue is manipulated, is counterbalanced by
the enhanced visualization offered by the
three-dimensional view of pseudocyst cavity to
facilitate its debridement. 
The robotic approach may represent an
attractive alternative, but unfortunately only
few authors reported their experience in 
robotic PPs treatment, and most of them are
limited to small case series (17-18, 42).
Considering our early experience, the total
hospital cost was not analyzed for our cohort of
patients. The experience of other authors
seems to suggest that endoscopic approach is
associated with lower hospital cost when 
compared with surgery (30). Conceivably, with
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the advent of newer competing systems for
robotic surgery becoming available on the
market, this cost differential may narrow
although further studies are required in this
area. With increasing expertise, this may lead
to greater utilization of this promising 
platform in difficult operative scenarios in the
management of pancreatic fluid collections in
the near future.
Conclusion
Robotic surgery is a safe and feasible approach
in the management of patients with pancreatic
pseudocyst requiring surgical intervention. 
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